Merck said on Monday it would split its business into two, creating ⁠a division for its cancer franchise while grouping its ​non-oncology treatments separately.

MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The ...

Merck MRK is focusing on driving long-term growth through the newer products and a promising set of pipelines as its ...

In the latest close session, Merck (MRK) was down 1.18% at $114.50. This move was narrower than the S&P 500's daily loss of 1.36%. Elsewhere, the Dow saw a downswing of 1.64%, while the tech-heavy ...

Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's once-yearly parasiticide treatment.

Johnson & Johnson JNJ and Merck MRK are among the top U.S. healthcare giants, making them ideal candidates for a direct ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund” ...

Oct 7 (Reuters) - Merck (MRK.N), opens new tab is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine in order to ward off competition, a ...

Shares of Merck & Co. Inc. MRK slipped 1.18% to $114.50 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.36% to 6,624.70 ...

We believe that the pharmaceuticals giant Merck (NYSE: MRK) is currently a better pick over its peer, AbbVie stock. MRK stock trades at 14x forward earnings, versus 20x for ABBV. We think this gap in ...

Today's Research Daily features new research reports on 16 major stocks, including Merck Co., Inc. (MRK), TotalEnergies SE ...

Employee volunteer program brings hands-on science learning to communities worldwide More than 600.000 students reached and ...